UPDATE: UBS Upgrades Edwards Lifesciences (EW) to Buy
Tweet Send to a Friend
(Updated - February 2, 2022 3:21 AM EST)
UBS analyst Matthew Taylor upgraded Edwards Lifesciences (NYSE: EW) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS analyst Matthew Taylor upgraded Edwards Lifesciences (NYSE: EW) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
